CN Bio Information
Summary
CN Bio is a private company that has been in the industry for 16 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by David Hughes. Its headquarters is located at Cambridge, England, GB. The number of employees ranges from 25 to 100. The annual revenue of CN Bio varies between 100K and 5.0M. Total funding of the company - $9.9M. To connect with CN Bio employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
Specialties
Organ-on-a-chip, Hepatitis B, drug discovery, liver disease, containment level 3 laboratory, microfluidic cell culture, precision biology, non-alcoholic steatohepatitis, Organ-on-Chip, Preclinical drug discovery, Microphysiological systems, Safety Toxicology, non-alcoholic fatty liver disorder, Contract Research Services, PhysioMimix OOC, Drug-induced liver injury, ADME, disease modeling, 3D cell culture, Aminal alternative, New Alternative approaches, COVID 19, Drug absorption, Drug metabolism, Bioavailability, Respiratory infection, DILI
SIC Code
2836
Founded
2008
Estimated Annual Revenue
$100K - 5.0M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2000 | Public Company | 100 - 250 | 34.8M | $211.4M | |
| 2014 | Privately Held | 1 - 25 | < 1M | $68.4M | |
| 2014 | Privately Held | 100 - 250 | 22M | $143.8M | |
| 2013 | Privately Held | 100 - 250 | 3.5M | $31.4M | |
| 2006 | Public Company | 1 - 25 | 16M | $153.7M | |
| 2012 | Privately Held | 1 - 25 | 3M | $3M | |
| 2011 | Privately Held | 25 - 100 | 2M | $12.4M | |
| 2015 | Privately Held | 100-200 | < 1M | $0 | |
| 2009 | - | 100-200 | - | $- | |
| 2014 | - | 10-50 | - | $- | |
| - | Public Company | 10-50 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Length of Employment
